Drug Trial Radar · NCT03302845
A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects
Last checked: Nov 20, 2026Latest source record: Apr 25, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Sep 21, 2017
Primary completion
Oct 23, 2017
Study completion Nov 7, 2017
Sponsor
- Lead sponsor
- Lexicon PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Oct 5, 2017
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This drug-drug interaction study will evaluate the impact of two different acid reducing agents (from two different drug classes) co-administered with a single dose of telotristat ethyl.
Conditions
- Drug-drug Interaction
Interventions
Omeprazole 40 MGDrug
Omeprazole 40 mg capsule
Famotidine 40 mgDrug
Famotidine 40 mg tablet
Telotristat ethyl 250 mgDrug
Telotristat ethyl 250 mg tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum observed concentration of telotristat ethylTime frame: 7 days
- Time of maximum observed concentration of telotristat ethylTime frame: 7 days
- Area under the plasma concentration-time curve beginning from the first dose until the last quantifiable concentration of telotristat ethylTime frame: 7 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Covance Clinical Research Unit
Dallas, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.